REQUEST A DEMO
Total
USD $0.00
Search more companies

Sciencepharma Sp. z o.o. sp. j. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Sciencepharma Sp. z o.o. sp. j. Profile Updated: October 26, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Sciencepharma Sp. z o.o. sp. j. is based in Poland. The head office is in Warsaw. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on January 29, 2021. There was a net sales revenue drop of 4.27% reported in Sciencepharma Sp. z o.o. sp. j.’s latest financial highlights for 2020. Its’ total assets recorded a negative growth of 23.5%.

Headquarters
Ul. Chelmska 30/34
Warsaw; Mazowieckie; Postal Code: 00-725

Contact Details: Purchase the Sciencepharma Sp. z o.o. sp. j. report to view the information.

Website: http://www.sciencepharma.pl

Basic Information
Outstanding Shares:
Purchase the Sciencepharma Sp. z o.o. sp. j. report to view the information.
Financial Auditors:
Purchase the Sciencepharma Sp. z o.o. sp. j. report to view the information.
Incorporation Date:
January 29, 2021
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Sciencepharma Sp. z o.o. sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-4.27%
Total operating revenue
-3.88%
Operating profit (EBIT)
649.78%
EBITDA
583.47%
Net Profit (Loss) for the Period
N/A
Total assets
-23.5%
Total equity
-27.89%
Operating Profit Margin (ROS)
2.54%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.01%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?